Biopharmaceutical Companies in BioPortfolio's Corporate Database
Biopharmaceutical company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Biopharmaceutical companies that have been added to our BioPortfolio's life-science corporate directory.
Search For More Biopharmaceutical Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Biopharmaceutical Companies.
More Information about Biopharmaceutical on BioPortfolio
We have published hundreds of Biopharmaceutical news stories on BioPortfolio along with dozens of Biopharmaceutical Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Biopharmaceutical for you to read.
Showing "biopharmaceuticals biopharmaceutical" Companies 1 to 25 of 1,100+
TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell death pathways to treat debilitating diseases and conditions. The Companyâs SMAC mimetics neutralize critical blocks in the apoptosis pathway to destroy cancer cells selectively. TetraLogicâs necr...
Transgene (NYSE-Euronext: TNG), a member of the Institut Mérieux Group, is a biopharmaceutical company. It creates, develops and manufactures targeted immunotherapeutics for the treatment of cancers and infectious diseases. Transgeneâs products are major technological breakthroughs. They use well tolerated viruses to indirectly or directly kill infected...
AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of $32.8 billion in 2009. In the United States, AstraZe...
Established in 2002 by its founding directors, Nigel Johnson and Mark Drinkwater to address the information and literature management needs of biopharmaceutical companies. Global leader in its field, specialising in Product Literature Database (PLD) systems and “Downstream Workflow Applications” for key user groups in the pharmaceutical industry. The Pi2 management team b...
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, is a biopharmaceutical company developing novel therapeutics based on a breakthrough in biology known as RNA interference, or RNAi; a discovery that enables the creation of a broad new class of human therapeutics. Using RNAi, Alnylam has built a product platform to develop a deep pipeline of drug products to treat a wide array of important di...
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk...
Tokai Pharmaceuticals is a U.S. biopharmaceutical company focused on developing new treatments for prostate cancer. The companyâs lead drug candidate, TOK-001, is the first investigational new drug that can decrease overall androgen receptor levels in prostate tumors and in which three distinct mechanisms of action are combined in one oncotherapeutic....
Alvine Pharmaceuticals, Inc. is a private, clinical-stage, specialty biopharmaceutical company located in San Carlos, CA, focused on the development of biologics targeting autoimmune and inflammatory diseases, including celiac disease. Alvine is focusing clinical development efforts on ALV003, an investigational drug in Phase 2 trials that could potentiall...
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs and vaccines. Working with some of the largest pharmaceutical organisations in the world, Xenetic provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas. Xenetic are also a...
Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those...
Verastem, Inc. is a private biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers s...
Enzo Biochem, Inc., is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including exotic tests, to the medical community. Since our founding in 1976, our strategic focus has been on the development...
Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis intends to target development programs at specific subsets of cancer populations, and will simultaneously develop diagnostic tools that direct a compound in development to the population that is most...
Mirus Bio Corporation is a biopharmaceutical company focused on discovering, developing and commercializing innovative nucleic acid based technologies and products. The company currently markets a range of innovative transfection and labeling reagents worldwide, and is developing therapies based on its proprietary Pathway IVâ„¢ delivery protocol.Pathway IVâ„¢ is a clinically practical proc...
Healthcare - A Quickly Expanding Market Healthcare is a significant and growing portion of the U.S. economy. U.S. expenditures are predicted to out-pace the broader economy and to top $4 trillion by the year 2015. With those figures in mind, NEA has significantly added to and strengthened its healthcare investing team in recent years. NEA believes that the healthcare sector will offer outstandi...
We are a biopharmaceutical company with a different approach to medicine. We develop drugs that are easier to take, safer to use, longer lasting and more effective. We look closely at existing therapies, and leverage our knowledge and extensive development expertise to evaluate how they can more effectively impact patients’ lives.Just over 15 years ago, our company was founded on breakthrou...
Neurogenetic Pharmaceuticals, Inc.
Neurogenetic Pharmaceuticals, Inc. (NGP) is a biopharmaceutical discovery and development company founded in 2009 which is focused on developing innovative drug therapies for use in the treatment of neurodegenerative disorders such as Alzheimerâs disease. Based in San Diego, Calif., the companyâs next objective is to obtain an Investigational New...
Ipsen is a global biopharmaceutical group, with sales exceeding 1 billion euros in 2009. The Group has total worldwide staff of more than 4,400 employees, of which nearly 900 contribute to the discovery and development of innovative drugs for patient care. Ipsenâs development strategy is based on fast growing specialty care drugs in oncology, endocrin...
Kamada is a public biopharmaceutical company (TASE: KMDA) developing, producing and marketing a line of specialty life-saving biopharmaceuticals. Licensed and marketed worldwide, several of these specialty therapeutics are currently undergoing advanced clinical trials. Kamada is currently in the process of conducting a clinical trial with its second genera...
Relypsa, Inc. is a, clinical-stage biopharmaceutical company leading the discovery and development of novel non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases. Relypsa's lead product candidate is RLY5016, a non-absorbed potassium binder for the treatment of hyperkalemia. Relypsa is dedicated to the discovery of add...
Itero Biopharmaceuticals, Inc.
Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical and commercial advantages over currently marketed alternatives. Itero is led by an executive team with 100+ collective years of successful experience in the development, manufacturi...
KTYHERA Biopharmaceuticals, Inc.
KYTHERA is a privately-held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic market. The aesthetic market is characterized by an aging population, increasing discretionary income and an evolution of patient preference towards care that focuses on quality o...
Doctor Evidence is the leader in the development of digital software technologies and services that find/store/translate and deliver the evidence, from clinical studies, to Life Science, Healthcare, Academic and Government organizations. The DRE database software enable the user to conduct meta and other analyses with the highest level of accuracy,...
MingSight Pharmaceuticals is a privately held emerging biopharmaceutical company focused on the research and development of ophthalmic therapeutics to improve the care of patients with serious eye diseases. MingSight is committed to building a world-class pipeline through the identification, acquisition, and development of innovative ophthalmic compounds....
Bayhill Thereapeutics is a clinical-stage biopharmaceutical company at the forefront of developing novel and targeted treatment candidates for autoimmune diseases. Leveraging its proprietary therapeutic BHT-DNA⢠platform, the Companyâs product candidates have been designed to restore the immune system to its normal state, known as âtolerance,â...
